Medtronic's pending $43 billion acquisition of Covidien could trigger 'golden parachute' provisions worth nearly $80 million for Covidien's senior management team.
If the top executives at Covidien decide to leave the company after a $43 billion acquisition by Medtronic goes through, they'll do it under a golden parachute worth a collective $80 million, regulatory filings show.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1pcFAPc
Cap comentari:
Publica un comentari a l'entrada